Revision summary
India and South Africa asked for a wide TRIPS waiver on COVID health products. The 2022 Ministerial Decision was a limited, conditional easing for vaccines. Tests and treatments were not given the same treatment. Technology transfer, not only law, remained the production bottleneck. The outcome was a compromise that preserved TRIPS more than it waived it.
Model answer
Introduction
India and South Africa proposed a broad TRIPS waiver in 2020 so that patents would not block COVID-19 vaccines, diagnostics, and therapeutics. The June 2022 Ministerial Decision was a narrower, time-bound compromise. It was not the waiver as drafted.
Body
What a TRIPS waiver would have been
- A waiver would have suspended specified TRIPS obligations for a set of COVID products so that more producers could copy and export without each patent-holder’s permission.
- Developing-country demand was for speed, coverage of vaccines plus treatments and tests, and simple eligibility.
What the 2022 decision was
- Members authorised a limited easing of compulsory-licensing rules for COVID-19 vaccines, with conditions on eligible members, duration, and notification.
- Diagnostics and therapeutics were left for later discussion, not covered in the same way.
- Legal complexity remained. Many manufacturers still needed technology transfer, not only a legal permission.
- Export and eligibility clauses were tighter than the India–South Africa text.
Comment
- Keohane’s regime view fits: the WTO produced a bargain that kept the TRIPS regime standing rather than opening a hole in it.
- Cox’s view also fits: intellectual-property order serving research firms in the core was protected while a public-health emergency was met with a minimum deal.
- India could still use existing TRIPS flexibilities and its own vaccine production. The political point is that the club did not rewrite IP for the South.
- Calling the outcome a waiver in headlines was inaccurate. It was a compromise that left TRIPS largely intact.
Flow diagram
flowchart TD P[India South Africa waiver 2020] --> M[WTO 2022 Ministerial] M --> V[Limited vaccine CL ease] M --> X[Diagnostics therapeutics deferred] V --> T[TRIPS regime still standing]
Conclusion
The COVID-19 vaccine decision at the WTO eased some compulsory-licensing steps for vaccines. It was not the broad TRIPS waiver India and South Africa sought. The regime survived the pandemic with a narrow carve-out.
Quick related
Students also ask
-
What are the challenges and limitations in India - Iran relations?
Next question on this syllabus topic (2023 · Q7(c)). View answer →
-
Did India stop making vaccines because there was no waiver?
No. Indian firms produced large volumes under other arrangements. The waiver fight was about global legal space and later products, not about a total stop in Pune or Hyderabad.
-
Why do writers still say waiver?
Political branding. The legal text is a limited decision on vaccine compulsory licensing, not a general TRIPS holiday.
PYQ trend
When UPSC asked this
Related PYQs from other years, newest first. Open a question to read it.
-
2023 · Q1(a) · PSIR GS 2 · 10 marks
What are the crucial functions of empirical political theory in Comparative Politics? -
2023 · Q1(b) · PSIR GS 2 · 10 marks
What are the difficulties faced by a political theorist in comparing the States? -
2023 · Q1(c) · PSIR GS 2 · 10 marks
How does democratic politics construct citizenship? -
2023 · Q3(c) · PSIR GS 2 · 15 marks
Narrate the various ways in which rapid environmental degradation is posing a serious threat to human security. Illustrate your answer with suitable examples -
2023 · Q4(b) · PSIR GS 2 · 15 marks
What do you mean by offensive and defensive realism? -
2023 · Q7(c) · PSIR GS 2 · 15 marks
What are the challenges and limitations in India - Iran relations? -
2023 · Q8(c) · PSIR GS 2 · 15 marks
Discuss the major drivers of India's interests in Africa -
2022 · Q1(a) · PSIR GS 2 · 10 marks
Discuss the main limitations of the comparative method to the study of Political Science.
More from this topic
Q7(c) · UPSC Mains 2025 · PSIR GS 2 · 15 marks
NonAlignment 2·0 underscores India's unique aspiration to emerge as a site for an alternative universality. Comment
Comparative Politics
NonAlignment 2.0 (2012) restated strategic autonomy for a China-first, post-NAM world: partner the U.S., do not join it. Alternative universality means rules others can inhabit without becoming Western or Chinese tributaries. India’s civilisational pluralism, Global South voice, and issue-based coalitions are the claimed site. The aspiration is coherent; capacity in the neighbourhood and in manufacturing is the constraint. The risk is exceptionalism dressed as universality.
Q7(b) · UPSC Mains 2025 · PSIR GS 2 · 15 marks
Trump's unilateral imposition of reciprocal tariffs on scores of countries poses impending threat to the future of the rule-based multilateral global trading system under the WTO. What options do the WTO members have to salvage the organization?
Comparative Politics
Trump’s 2025 reciprocal tariffs, on top of a blocked Appellate Body, treat MFN as optional and threaten WTO as policeman. Salvage options: restore appeals or widen MPIA, plurilaterals, a subsidy-for-S&DT reform bargain, G20 politics, and FTA hedges. India’s stake is public stockholding, digital rules and a forum in which power is not the only law. A variable-geometry WTO is more likely than a 1995 restoration. Letting the organisation die would leave only tariff nationalism.
Q6(c) · UPSC Mains 2025 · PSIR GS 2 · 15 marks
The tariff threats have pushed India and the European Union closer. Evaluate the India-EU partnership
Comparative Politics
U.S. reciprocal tariffs in 2025 threatened both Indian and EU exports and compressed FTA timelines. The partnership already includes TTC, climate talk, student mobility and a values vocabulary. Friction remains on agriculture, data, CBAM, Russia and human-rights politics. Directionally closer is true; a finished trade-and-tech pole is not yet true. India–EU is the best Western hedge if Washington stays protectionist, not a substitute for U.S. defence enablers.
Toppers' copies
Toppers' copies for this question will be uploaded soon.